EUCRATES BIOMEDICAL ACQU COR's ticker is EUCR and the CUSIP is G3141W106. A total of 40 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $307 | -44.2% | 30,622 | -44.9% | 0.00% | – |
| Q2 2022 | $550 | -100.0% | 55,622 | -90.0% | 0.00% | -100.0% |
| Q1 2022 | $5,448,000 | +1488.3% | 553,622 | +1476.7% | 0.00% | – |
| Q4 2021 | $343,000 | -5.8% | 35,112 | -5.6% | 0.00% | – |
| Q3 2021 | $364,000 | +233.9% | 37,202 | +235.2% | 0.00% | – |
| Q2 2021 | $109,000 | – | 11,099 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Altium Capital Management LP | 400,000 | $3,936,000 | 1.32% |
| Integrity Capital Management (HK) Ltd | 9,755 | $96,000 | 0.50% |
| 683 Capital Management, LLC | 600,000 | $5,904,000 | 0.32% |
| Cowen Investment Management LLC | 124,726 | $1,227,000 | 0.26% |
| CVI Holdings, LLC | 367,552 | $3,617,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 999,999 | $9,840,000 | 0.22% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $1,968,000 | 0.20% |
| First Trust Capital Management L.P. | 167,525 | $1,648,000 | 0.18% |
| SkyView Investment Advisors, LLC | 71,773 | $706,000 | 0.17% |
| Hudson Bay Capital Management LP | 512,528 | $5,048,000 | 0.07% |